Search
for
Sort by
Research 571–600 of 1000+
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Melatonin Receptors and Their Role in Human Diseases
- Androgenisierung
- Main Plenary Sessions: Summaries of Papers
- Obstetric and Gynecologic Dermatology
- Alopecia prevention during chemotherapy: from the benchmark to real clinical practice. A prospective study
- Nails and hair
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence
- Unveiling Therapeutic Potential of Yoga Mitigating Oxidative Stress and Mitochondrial Dysfunction in PCOS: A Randomized Controlled Trial
- A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study
- Icariside II inhibits gastric cancer progression by suppressing the Wnt/β-catenin signaling pathway
- Hair, Hormones, and High-Risk Prostate Cancer
- Treatment of the adolescent patient with polycystic ovary syndrome
- Association of Spironolactone Use With Risk of Cancer
- Application and Progress of Cultured Models of Gallbladder Carcinoma
- Ausgeprägte Virilisierung in der Postmenopause - eine Falldarstellung
- Schimmelpenning syndrome with dydimosis aplasticosebacea in a one-month-old girl
- Protein Kinase C as a Therapeutic Target
- Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
- Non-histone Methylation of SET7/9 and its Biological Functions
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Ectopic Expression of a Truncated Isoform of Hair Keratin 81 in Breast Cancer Alters Biophysical Characteristics to Promote Metastatic Propensity
- Moving Chemoprevention Forward into the Most Promising Areas of Study
- LACK OF EFFECT OF OESTROGENS ON ADRENAL ANDROGEN SECRETION IN CHILDREN AND ADOLESCENTS WITH A COMMENT ON OESTROGENS AND PUBIC HAIR GROWTH
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Amphiregulin in Fibrotic Diseases and Cancer